Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial

BACKGROUND: SARS-CoV-2 infection presents a high transmission in the group of health professionals in Spain (12-15% infected). Currently there is no accepted chemoprophylaxis but hydroxychloroquine (HDQ) is known to inhibit the coronavirus in vitro. Our hypothesis is that oral administration of hydr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuadrado-Lavín, Antonio, Olmos, José Manuel, Cifrian, José Manuel, Gimenez, Teresa, Gandarillas, Marco Antonio, García-Saiz, Mar, Rebollo, Maria Henar, Martínez-Taboada, Victor, López-Hoyos, Marcos, Fariñas, María Carmen, Crespo, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268173/
https://www.ncbi.nlm.nih.gov/pubmed/32493494
http://dx.doi.org/10.1186/s13063-020-04400-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268173/
https://www.ncbi.nlm.nih.gov/pubmed/32493494
http://dx.doi.org/10.1186/s13063-020-04400-4

Ejemplares similares